21
cfr
parts
520
and
556
animal
drugs
,
feeds
,
and
related
products
;
fenbendazole
suspension
<
agency
>
agency
:
food
and
drug
administration
,
hhs
.
<
agency
>
<
action
>
action
:
final
rule
.
<
action
>
<
summary
>
summary
:
the
food
and
drug
administration
(
fda
)
is
amending
the
animal
drug
regulations
to
reflect
approval
of
a
supplemental
new
animal
drug
application
(
nada
)
filed
by
hoechstroussel
hoechst
roussel
agrivet
agri
vet
co
.
the
supplemental
nada
provides
for
oral
administration
of
fenbendazole
suspension
to
goats
as
an
anthelmintic
.
the
regulations
are
also
amended
to
establish
a
tolerance
for
drug
residues
in
edible
goat
tissues
.
<
summary
>
<
date
>
effective
date
:
05/25/1994
.
<
date
>
<
further
>
for
further
information
contact
:
george
k
.
haibel
,
center
for
veterinary
medicine
(
hfv133
hfv
,
food
and
drug
administration
,
7500
standish
pl
,
rockville
,
md
20855
,
3015941644
.
<
further
>
<
supplem
>
supplementary
information
:
hoechstroussel
hoechst
roussel
agrivet
agri
vet
co
,
rt
.
202206
north
,
somerville
,
nj
08876
,
filed
a
supplemental
nada
128620
that
provides
for
oral
administration
of
a
suspension
containing
10
percent
fenbendazole
to
nonlactating
goats
for
removal
and
control
of
stomach
and
intestinal
worms
haemonchus
contortus
and
ostertagia
circumcincta
.
.
also
,
a
tolerance
for
residues
of
fenbendazole
and
its
metabolites
in
edible
goat
tissues
is
established
.
approval
is
based
in
part
on
data
and
information
in
public
master
file
(
pmf
)
5118
established
under
the
interregional
research
project
no
.
4
(
ir4
,
northcentral
region
,
michigan
state
university
,
east
lansing
,
mi
48824
.
the
supplement
is
approved
as
of
04/25/1994
,
and
the
regulations
are
amended
in
21
cfr
520
905a
and
556
275
to
reflect
the
approval
.
the
basis
for
approval
is
discussed
in
the
freedom
of
information
summary
.
additionally
,
the
regulations
for
tolerances
and
safe
concentrations
for
residues
of
the
drug
or
its
metabolites
in
cattle
and
swine
are
editorially
revised
to
remove
any
reference
to
safe
concentrations
because
they
are
irrelevant
for
residue
monitoring
purposes
.
in
accordance
with
the
freedom
of
information
provisions
of
part
20
(
21
cfr
part
20
)
and
§
514
11
)
(
21
cfr
514
11
,
a
summary
of
safety
and
effectiveness
data
and
information
submitted
to
support
approval
of
this
application
may
be
seen
in
the
dockets
management
branch
(
hfa305
hfa
,
food
and
drug
administration
,
rm
.
123
,
12420
parklawn
dr
,
rockville
,
md
20857
,
between
9
am
.
and
4
pm
,
monday
through
friday
.
under
section
512c2fiii
)
of
the
federal
food
,
drug
,
and
cosmetic
act
(
21
usc
.
360bc2fiii
,
this
approval
does
not
qualify
for
marketing
exclusivity
because
no
new
clinical
or
field
investigations
(
other
than
bioequivalence
or
residue
studies
)
and
no
new
human
food
safety
studies
(
other
than
bioequivalence
or
residue
studies
)
essential
to
approval
of
the
supplement
were
conducted
or
sponsored
by
the
applicant
.
the
agency
has
carefully
considered
the
potential
environmental
effects
of
this
action
.
fda
has
concluded
that
the
action
will
not
have
a
significant
impact
on
the
human
environment
,
and
that
an
environmental
impact
statement
is
not
required
.
the
agencys
finding
of
no
significant
impact
and
the
evidence
supporting
that
finding
,
contained
in
an
environmental
assessment
,
may
be
seen
in
the
dockets
management
branch
(
address
above
)
between
9
am
.
and
4
pm
,
monday
through
friday
.
list
of
subjects
21
cfr
part
520
animal
drugs
.
21
cfr
part
556
animal
drugs
,
foods
.
therefore
,
under
the
federal
food
,
drug
,
and
cosmetic
act
and
under
authority
delegated
to
the
commissioner
of
food
and
drugs
and
redelegated
to
the
center
for
veterinary
medicine
,
21
cfr
parts
520
and
556
are
amended
as
follows
:
part
520oral
dosage
form
new
animal
drugs
1
.
the
authority
citation
for
21
cfr
part
520
continues
to
read
as
follows
:
authority
:
sec
.
512
of
the
federal
food
,
drug
,
and
cosmetic
act
(
21
usc
.
360b
.
2
.
section
520
905a
is
amended
by
adding
new
paragraph
(
d3
)
to
read
as
follows
:
§
520
905a
fenbendazole
suspension
.
*
*
*
*
*
*
*
*
*
*
(
d
)
*
*
*
*
*
*
(
3
)
goats
_
i
)
amount
.
.
administer
orally
5
milligrams
per
kilogram
of
body
weight
(
23
milligrams
per
pound
.
(
ii
)
indications
for
use
.
.
for
the
removal
and
control
of
stomach
and
intestinal
worms
haemonchus
contortus
and
ostertagia
circumcincta
(
iii
)
limitations
.
.
retreatment
may
be
needed
after
4
to
6
weeks
.
goats
must
not
be
slaughtered
for
food
within
6
days
following
last
treatment
.
do
not
use
in
lactating
goats
.
federal
law
restricts
this
drug
to
use
by
or
on
the
order
of
a
licensed
veterinarian
.
*
*
*
*
*
*
*
*
*
*
part
556tolerances
for
residues
of
new
animal
drugs
in
food
3
.
the
authority
citation
for
21
cfr
part
556
continues
to
read
as
follows
:
authority
:
secs
.
402
,
512
,
701
of
the
federal
food
,
drug
,
and
cosmetic
act
(
21
usc
.
342
,
360b
,
371
.
4
.
section
556
275
is
revised
to
read
as
follows
:
§
556
275
fenbendazole
.
(
a
)
cattle
and
goats
.
.
a
tolerance
of
08
part
per
million
is
established
for
parent
fenbendazole
(
the
marker
residue
)
in
the
liver
of
cattle
and
goats
.
<
footnote
>
<
footname
>
<
footname
>
as
used
in
this
section
:
`
tolerance
'
refers
to
a
concentration
of
a
marker
residue
in
the
target
tissue
selected
to
monitor
for
total
residues
of
the
drug
in
the
target
animal
.
<
footnote
>
(
b
)
swine
.
.
a
tolerance1
for
marker
residues
of
fenbendazole
in
swine
is
not
needed
.
dated
:
05/17/1994
.
<
supplem
>
<
signer
>
richard
h
.
teske
,
<
signer
>
<
signjob
>
acting
director
,
center
for
veterinary
medicine
.
<
signjob
>
<
frfiling
>
[
fr
doc
.
9412805
filed
05/24/1994
;
845
am
]
<
frfiling
>
<
billing
>
billing
code
416001f
<
billing
>
<
text
>
